Company intelligence / Profile preview

Natural Sciences

Ownership: Private
Development stage: Other

Overview

Natural Sciences is a biotechnology company focused on the discovery and development of novel therapeutics derived from natural sources. The company leverages a proprietary platform to identify and optimize bioactive compounds from diverse biological libraries, targeting unmet needs in oncology, infectious diseases, and inflammatory conditions. By combining traditional natural product chemistry with modern high-throughput screening and genomic analysis, Natural Sciences aims to unlock the therapeutic potential of complex molecules that are often difficult to synthesize. Their pipeline currently consists of several pre-clinical programs aimed at identifying lead candidates for further development.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Small moleculeNatural products
Industry: Biotech

Beyond the preview

Go deeper on Natural Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural Sciences.

Explore the full profile